Globitair

AstraZeneca profit jumps 23% on cancer drugs as it unveils major savings plan

EuroNewsUnited Kingdom

AstraZeneca's net profit jumped 23% in the third quarter on booming sales of its cancer drugs, as the British drugmaker unveiled a programme to save $1.5 billion (€1.34bn) a year to invest back into developing new medicines.

Read the full story at EuroNewsOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about United Kingdom